Sigma Healthcare Limited (SIGGF)
OTCMKTS · Delayed Price · Currency is USD
1.960
0.00 (0.00%)
Aug 12, 2025, 4:00 PM EDT
Sigma Healthcare Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Net Income | 541.01 | 304.33 | 385.93 | -175.98 | 228.97 |
Depreciation & Amortization | 35.27 | 95.51 | 136.45 | 38.79 | 23.51 |
Loss (Gain) From Sale of Assets | - | -10.09 | - | - | - |
Asset Writedown & Restructuring Costs | 0.53 | -2.4 | 0.22 | 12.19 | - |
Loss (Gain) on Equity Investments | -23.06 | -13.04 | -8.18 | -1.65 | -0.14 |
Stock-Based Compensation | 15.51 | 0.81 | 1.06 | 0.42 | 0.14 |
Other Operating Activities | -1.36 | -1.87 | -27.43 | 428.64 | -17.8 |
Change in Accounts Receivable | -294.32 | 112.71 | -137.23 | 53.18 | -108.9 |
Change in Inventory | -117.84 | 10.73 | -83.22 | 71.47 | -92.3 |
Change in Accounts Payable | 156.27 | 76.06 | -38.21 | -4.01 | 76.93 |
Change in Unearned Revenue | - | - | 26.18 | -77.93 | 137.21 |
Change in Income Taxes | -17.1 | -42.92 | 41.51 | -0.94 | 7.65 |
Change in Other Net Operating Assets | 12.84 | -65.34 | -3.61 | -5.56 | 4.56 |
Operating Cash Flow | 273.18 | 444.69 | 284.34 | 314.94 | 259.04 |
Operating Cash Flow Growth | -38.57% | 56.39% | -9.72% | 21.58% | - |
Capital Expenditures | -32.84 | -12.28 | -13.06 | -9.96 | -6.74 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.91 |
Cash Acquisitions | - | - | -4.85 | 4.25 | - |
Sale (Purchase) of Intangibles | -8.5 | - | - | - | - |
Investment in Securities | 1.22 | 39.06 | - | - | - |
Investing Cash Flow | 69.36 | 75.52 | -17.9 | -5.71 | -5.83 |
Long-Term Debt Issued | 855.92 | 448.51 | 2,401 | 5,175 | 4,720 |
Long-Term Debt Repaid | -913.07 | -606.94 | -2,510 | -5,017 | -4,614 |
Net Debt Issued (Repaid) | -57.15 | -158.44 | -109.24 | 158.57 | 106.57 |
Issuance of Common Stock | - | - | - | 51.72 | - |
Common Dividends Paid | -217.7 | -264.06 | -269.26 | -340 | -350 |
Other Financing Activities | -0.41 | -0.03 | 0.34 | 0.06 | -0.13 |
Financing Cash Flow | -275.26 | -422.52 | -378.16 | -129.66 | -243.57 |
Foreign Exchange Rate Adjustments | -0.8 | 0.98 | -0.5 | 0.02 | -0.07 |
Net Cash Flow | 66.48 | 98.67 | -112.23 | 179.59 | 9.58 |
Free Cash Flow | 240.34 | 432.4 | 271.28 | 304.98 | 252.3 |
Free Cash Flow Growth | -44.42% | 59.39% | -11.05% | 20.88% | - |
Free Cash Flow Margin | 7.29% | 13.99% | 9.06% | 12.60% | 10.06% |
Free Cash Flow Per Share | 0.15 | 0.28 | 0.17 | 0.27 | 0.24 |
Cash Interest Paid | - | - | - | - | 29.7 |
Cash Income Tax Paid | - | - | - | - | 96.45 |
Levered Free Cash Flow | 58.4 | 367.65 | 140.63 | 1,377 | - |
Unlevered Free Cash Flow | 98.55 | 401.18 | 165.15 | 1,400 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.